Are outcomes WORSE with tigecycline (Tygacil) compared with other antibiotics
October 2012
Please see the September 2013 FDA update regarding the increased risk of death with Tygacil
New evidence is saying "yes."
Initial studies suggested that tigecycline is comparable to vancomycin plus aztreonam for skin infections...imipenem for intra-abdominal infections...and levofloxacin for community-acquired pneumonia. But most of these patients weren't seriously ill.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote